Regulation of Inflammatory Cytokine Production by Bee Venom in Rat Chondrocytes

  • Kim, Eun-Jung (Department of Physical Therapy, College of Health and Wellfare, Dongshin University) ;
  • Kim, Gye-Yeop (Department of Physical Therapy, College of Health and Wellfare, Dongshin University)
  • Received : 2010.11.08
  • Accepted : 2010.12.14
  • Published : 2011.02.25

Abstract

Bee venom acupuncture (BVA), as a kind of herbal acupuncture, involved injecting diluted bee venom into acupoints and is used for pain, osteoarthritis and rheumatoid arthritis patients. BVA is growing in popularity, especially in Korea, and is used primarily for pain relief in many kinds of diseases. However, the effect of bee venom anti-inflammatory related action in lipopolysaccharide (LPS) induced chondrocyte stress have not been reported yet. The aim of this study was to investigate the effect of bee venom of cell viability and inflammatory cytokine in rat articular chondrocyte cultures stimulated with lipopolysaccharide. Inflammation was induced in rat chondrocytes by treatment with $10{\mu}g/m{\ell}$ LPS. The change of cell viability were decreased in chondrocytes after treatment with lipopolysaccharide. The cell viability revealed that BV exerted no significant cytotoxicity in the rat chondrocyte. Bee venom inhibited decreased cell viability in the presence of lipopolysaccharide ($10{\mu}g/m{\ell}$) in a dose dependent manner(0.1, 0.5, 1.0 and $5.0{\mu}g/m{\ell}$) at bee venom(p<0.05). Tumor necrosis factor (TNF)-${\alpha}$ production in the presence of lipopolysaccharide($1{\mu}g/m{\ell}$) was also inhibited in a dose dependent manner (p<0.05 from bee venom $0.1{\mu}g/m{\ell}$). Interleukin (IL)-6 production in the presence of lipopolysaccharide ($10{\mu}g/m{\ell}$) was inhibited as well (p<0.05 at bee venom 0.1, 0.5, 1.0 and $5.0{\mu}g/m{\ell}$, respectively). Our results demonstrate that bee venom was a anti-inflammatory agent of chondrocytes. Bee venom may exert its anti inflammatory effects through inhibition of TNF-${\alpha}$ and IL-6 synthesis, and may then pain relief and reduce the articular destruction.

Keywords

References

  1. Peyron, J.G. Epidemiologic and etiologic approach of osteoarthritis. Semin Arthritis Rheum. 8(4):288-306, 1979. https://doi.org/10.1016/0049-0172(79)90006-4
  2. Leveille, S.G., Ling, S., Hochberg, M.C., Resnick, H.E., Bandeen-Roche, K.J., Won, A., Guralnik, J.M. Widespread musculoskeletal pain and the progression of disability in older disabled women. Ann Intern Med. 18;135(12):1038-1046, 2001. https://doi.org/10.7326/0003-4819-135-12-200112180-00007
  3. Jordan, K.M., Arden, N.K., Doherty, M., Bannwarth, B., Bijlsma, J.W., Dieppe, P., Gunther, K., Hauselmann, H., Herrero-Beaumont, G., Kaklamanis, P., Lohmander, S., Leeb, B., Lequesne, M., Mazieres, B., Martin-Mola, E., Pavelka, K., Pendleton, A., Punzi, L., Serni, U., Swoboda, B., Verbruggen, G., Zimmerman-Gorska, I., Dougados, M. Standing Committee for International Clinical Studies Including Therapeutic Trials ESCISIT. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a task force of the standing committee for international clinical studies including therapeutic trials (ESCISIT). Ann Rheum Dis. 62(12):1145-1155, 2003. https://doi.org/10.1136/ard.2003.011742
  4. Brooks P. Inflammation as an important feature of osteoarthritis. Bull World Health Organ. 81(9):689-690, 2003.
  5. Garnero, P., Delmas, P.D. Biomarkers in osteoarthritis. Curr Opin Rheumatol. 15(5):641-646, 2003. https://doi.org/10.1097/00002281-200309000-00020
  6. Felson, D.T. Clinical practice. Osteoarthritis of the knee. N Engl J Med. 23;354(8):841-248, 2006. https://doi.org/10.1056/NEJMcp051726
  7. Witter, J., Dionne, R.A. What can chronic arthritis pain teach about developing new analgesic drugs? Arthritis Res Ther. 6(6):279-281, 2004. https://doi.org/10.1186/ar1450
  8. Goldring, M.B., Goldring, S.R. Osteoarthritis. J Cell Physiol. 213(3):626-634, 2007. https://doi.org/10.1002/jcp.21258
  9. Kammermann, J.R., Kincaid, S.A., Rumph, P.F., Baird, D.K., Visco, D.M. Tumor necrosis factor-alpha (TNF-alpha) in canine osteoarthritis: Immunolocalization of TNF-alpha, stromelysin and TNF receptors in canine osteoarthritic cartilage. Osteoarthritis Cartilage. 4(1):23-34, 1996. https://doi.org/10.1016/S1063-4584(96)80004-5
  10. Hochberg, M.C. Nutritional supplements for knee osteoarthritis-still no resolution. N Engl J Med. 354(8):858- 860, 2006. https://doi.org/10.1056/NEJMe058324
  11. Long, L., Soeken, K., Ernst, E. Herbal medicines for the treatment of osteoarthritis: a systematic review. Rheumatology(Oxford). 40(7):779-793, 2001. https://doi.org/10.1093/rheumatology/40.7.779
  12. Lee, J.D., Park, H.J., Chae, Y., Lim, S. An Overview of bee venom acupuncture in the treatment of arthritis. Evid Based Complement Alternat Med. 2(1):79-84, 2005. https://doi.org/10.1093/ecam/neh070
  13. Melchiorri, C., Meliconi, R., Frizziero, L., Silvestri, T., Pulsatelli, L., Mazzetti, I., Borzì, R.M., Uguccioni, M., Facchini, A. Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis. Arthritis Rheum. 41(12):2165-2174, 1998. https://doi.org/10.1002/1529-0131(199812)41:12<2165::AID-ART11>3.0.CO;2-O
  14. Pulsatelli, L., Dolzani, P., Piacentini, A., Silvestri, T., Ruggeri, R., Gualtieri, G., Meliconi, R., Facchini, A. Chemokine production by human chondrocytes. J Rheumatol. 26(9):1992-2001, 1999.
  15. Lee, M.S., Pittler, M.H., Shin, B.C., Kong, J.C., Ernst, E. Bee venom acupuncture for musculoskeletal pain: a review. J Pain. 9(4):289-297, 2008. https://doi.org/10.1016/j.jpain.2007.11.012
  16. Stuhlmeier, K.M. Apis mellifera venom and melittin block neither NF-kappa B-p50-DNA interactions nor the activation of NF-kappa B, instead they activate the transcription of proinflammatory genes and the release of reactive oxygen intermediates. J Immunol. 1;179(1):655-664, 2007.
  17. Saad Rached, I.C., Castro, F.M., Guzzo, M.L., de Mello, S.B. Anti-inflammatory effect of bee venom on antigen-induced arthritis in rabbits: influence of endogenous gluco-corticoids. J Ethnopharmacol. 130(1):175-178, 2010. https://doi.org/10.1016/j.jep.2010.04.015
  18. Son, D.J., Lee, J.W., Lee, Y.H., Song, H.S., Lee, C.K., Hong, J.T. Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacol Ther. 115(2):246-270, 2007. https://doi.org/10.1016/j.pharmthera.2007.04.004
  19. Kiepe, D., Andress, D.L., Mohan, S., Standker, L., Ulinski, T., Himmele, R., Mehls O., Tönshoff, B. Intact IGF-binding protein-4 and -5 and their respective fragments isolated from chronic renal failure serum differentially modulate IGF-I actions in cultured growth plate chondrocytes. J Am Soc Nephrol. 12(11):2400-2410, 2001.
  20. Denizot, F., Lang, R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods. 22;89(2):271-277, 1986. https://doi.org/10.1016/0022-1759(86)90368-6
  21. Gill, S.E., Bonnet, C.S., Suri, S., Wilson, D., Walsh, D.A. Neurovascular invasion at the osteochondral junction in osteoarthritis. Ann Rheum Dis. 66(11):1423-1428, 2007. https://doi.org/10.1136/ard.2006.063354
  22. Niissalo, S., Hukkanen, M., Imai, S., Tornwall, J., Konttinen, Y.T. Neuropeptides in experimental and degenerative arthritis. Ann N Y Acad Sci. 966: 384-399, 2002. https://doi.org/10.1111/j.1749-6632.2002.tb04239.x
  23. Conrozier, T., Chappuis-Cellier, C., Richard, M., Mathieu, P., Richard, S., Vignon, E. Increased serum C-reactive protein levels by immunonephelometry in patients with rapidly destructive hip osteoarthritis. Rev Rhum Engl Ed. 65: 759-765, 1998.
  24. Lories, R.J., Luyten, F.P. Bone morphogenetic protein signaling and arthritis. Cytokine Growth Factor Rev. 20(5-6):467-473, 2009. https://doi.org/10.1016/j.cytogfr.2009.10.009
  25. Chen, J., Lariviere, W.R. The nociceptive and antinociceptive effects of bee venom injection and therapy: a double-edged sword. Prog Neurobiol. 92(2):151-183, 2010. https://doi.org/10.1016/j.pneurobio.2010.06.006
  26. Klooster, A.R., Bernier, S.M. Tumor necrosis factor alpha and epidermal growth factor act additively to inhibit matrix gene expression by chondrocyte. Arthritis Res Ther. 7(1):127-138, 2005. https://doi.org/10.1186/ar1464
  27. Cunha, J.M., Cunha, F.Q., Poole, S., Ferreira, S.H. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist. Br J Pharmacol. 30(6): 1418-1424, 2000.
  28. Bernheim, H.A., Gilbert, T.M., Stitt, J.T.. Prostaglandin E levels in third ventricular cerebrospinal fluid of rabbits during fever and changes in body temperature. J Physiol. 301: 69-78, 1980.
  29. Kwon, Y.B., Yoon, S.Y., Kim, H.W., Roh, D.H., Kang, S.Y., Ryu, Y.H., Choi, S.M., Han, H.J., Lee, H.J., Kim, K.W., Beitz, A.J., Lee, J.H. Substantial role of locus coeruleus-noradrenergic activation and capsaicin-insensitive primary afferent fibers in bee venom's anti-inflammatory effect. Neurosci Res. 55(2):197-203, 2006. https://doi.org/10.1016/j.neures.2006.03.003
  30. Moon, D.O., Park, S.Y., Lee, K.J., Heo, M.S., Kim, K.C., Kim, M.O., Lee, J.D., Choi, Y.H., Kim, G.Y. Bee venom and melittin reduce proinflammatory mediators in lipopolysaccharide-stimulated BV2 microglia. Int Immuno-pharmacol. 7(8):1092-1101, 2007. https://doi.org/10.1016/j.intimp.2007.04.005
  31. Son, D.J., Lee, J.W., Lee, Y.H., Song, H.S., Lee, C.K., Hong, J.T. Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacol Ther. 115(2):246-270, 2007. https://doi.org/10.1016/j.pharmthera.2007.04.004
  32. Hadjipetrou-Kourounakis, L., Yiangou, M. Bee venom, adjuvant induced disease and interleukin production. J Rheumatol. 15(7):1126-1128, 1988.
  33. Lee, J.Y., Kang, S.S., Kim, J.H., Bae, C.S., Choi, S.H. Inhibitory effect of whole bee venom in adjuvant-induced arthritis. In Vivo. 19(4):801-805, 2005.